CMDh Workplan to 2025 – Published CMDh Workplan to 2025 – Published The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published its... CMDh Workplan to 2025 – Published
MHRA Public Assessment Report – Reclassification of Sudafed Plus Blocked Nose 1mg/50mg/ml Nasal Spray Solution MHRA Public Assessment Report – Reclassification of Sudafed Plus Blocked Nose 1mg/50mg/ml Nasal Spray Solution MHRA has published the Public... MHRA Public Assessment Report – Reclassification of Sudafed Plus Blocked Nose 1mg/50mg/ml Nasal Spray Solution
EU Commission – FAQ on Medicines and Medical Devices Concerning Sanctions Against Russia EU Commission – FAQ on Medicines and Medical Devices Concerning Sanctions Against Russia The Commission has published “... EU Commission – FAQ on Medicines and Medical Devices Concerning Sanctions Against Russia
CMDh July 2022 Meeting – Report CMDh July 2022 Meeting – Report The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published... CMDh July 2022 Meeting – Report
HPRA – Note for Non-Pharmacy Retail Advertising of Medicines HPRA – Note for Non-Pharmacy Retail Advertising of Medicines The Health Products Regulatory Authority (HPRA) has published a note to... HPRA – Note for Non-Pharmacy Retail Advertising of Medicines
Nitrosamines – Extension of Deadline for Submitting Variation Applications for Chemical Medicines Nitrosamines – Extension of Deadline for Submitting Variation Applications for Chemical Medicines The Committee for Medicinal Products for Human Use... Nitrosamines – Extension of Deadline for Submitting Variation Applications for Chemical Medicines
New Commissioners Appointed to the Commission on Human Medicines New Commissioners Appointed to the Commission on Human Medicines Professor Tony Williams, Professor David Hunt, Professor David Dockrell, Dr Gerri... New Commissioners Appointed to the Commission on Human Medicines
Big Data – HMA-EMA Joint Big Data Taskforce Workplan Update: 2022-2025 Big Data – HMA-EMA Joint Big Data Taskforce Workplan Update: 2022-2025 The Big Data Steering Group set... Big Data – HMA-EMA Joint Big Data Taskforce Workplan Update: 2022-2025
EU Pharma Legislation Review – Proposed Amendments to Directive 2001/83 EU Pharma Legislation Review – Proposed Amendments to Directive 2001/83 AESGP are working with EFPIA and Medicines for Europe on... EU Pharma Legislation Review – Proposed Amendments to Directive 2001/83
EMA Guideline on the Chemistry of Active Substances – Public Consultation EMA Guideline on the Chemistry of Active Substances – Public Consultation The EMA (European Medicines Agency) has published the... EMA Guideline on the Chemistry of Active Substances – Public Consultation
EMA Q&A and Report Published on Boric Acid and Borates used as Excipients in Human Medicines EMA Q&A and Report Published on Boric Acid and Borates used as Excipients in Human Medicines Further to the European... EMA Q&A and Report Published on Boric Acid and Borates used as Excipients in Human Medicines
Fourth Watch List of Substances Published in Official Journal Fourth Watch List of Substances Published in Official Journal The Commission Implementing Decision (EU) 2022/1307 of 22 July 2022 establishing... Fourth Watch List of Substances Published in Official Journal
